LAPOINTE ANTHONY GREGG
SEC CIK 1331860 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RIGL | RIGEL PHARMACEUTICALS INC | Dir | 18.2K | — | — | 5 | 2022-05-20 | 2026-05-15 |
Most active insiders at RIGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ali-Jackson Kamil | Dir | — | $160.4K |
| 2 | MOOS WALTER H | Dir | — | $145.4K |
| 3 | Rojkjaer Lisa | EVP, Chief Medical Off | — | — |
| 4 | Santos David A | EVP, Chief Commercial Off | — | — |
| 5 | HANNAH ALISON L. | EVP, Chief Medical Off | — | — |
| 6 | Furey Raymond J. | EVP, GC, CCO, Corp Sec | — | — |
| 7 | Schorno Dean L | EVP, CFO | — | — |
| 8 | Frohlich Mark W | Dir | — | — |
| 9 | Wasman Jane | Dir | — | — |
| 10 | LAPOINTE ANTHONY GREGG | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 20:49 | 2026-05-15 | RIGL | RIGEL PHARMACEUTICALS INC | LAPOINTE ANTHONY GREGG | Dir | A - Grant | $0.00 | +5,750 | 18.2K | +46% | $0 | |
| D | 2025-05-28 | 2025-05-23 | RIGL | RIGEL PHARMACEUTICALS INC | LAPOINTE ANTHONY GREGG | Dir | A - Grant | $0.00 | +2,500 | 12.5K | +25% | $0 |
| D | 2024-05-29 | 2024-05-25 | RIGL | RIGEL PHARMACEUTICALS INC | LAPOINTE ANTHONY GREGG | Dir | A - Grant | $0.00 | +25.0K | 100.0K | +33% | $0 |
| D | 2023-07-12 | 2023-05-26 | RIGL | RIGEL PHARMACEUTICALS INC | LAPOINTE ANTHONY GREGG | Dir | A - Grant | $0.00 | +25.0K | 75.0K | +50% | $0 |
| D | 2022-05-23 | 2022-05-20 | RIGL | RIGEL PHARMACEUTICALS INC | LAPOINTE ANTHONY GREGG | Dir | A - Grant | $0.00 | +25.0K | 50.0K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations